[Chemotherapy of metastasizing breast cancer].
Treatment strategies for metastatic breast cancer are determined by various prognostic factors. The main two factors are if the patients are of high or low risk. Primary treatment consists of combinations of various drugs with (VAC) or without adriamycin (CMF). Advantages, disadvantages and side effects of these treatment regimens of those (above) as well as other treatment strategies are being discussed.
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects / Q000627:therapeutic use*; D001943:Breast Neoplasms / Q000188:drug therapy*; D003520:Cyclophosphamide / Q000008:administration & dosage; D003609:Dactinomycin / Q000008:administration & dosage; D005260:Female; D005472:Fluorouracil / Q000008:administration & dosage; D006801:Humans; D008727:Methotrexate / Q000008:administration & dosage; D009362:Neoplasm Metastasis; D011379:Prognosis; D014750:Vincristine / Q000008:administration & dosage
D003609:Dactinomycin; D014750:Vincristine; D003520:Cyclophosphamide; D005472:Fluorouracil; D008727:Methotrexate
Die Chemotherapie des metastasierenden Mammakarzinoms.